Scientists from Northwestern Medicine and Epicore Biosystems have developed a wearable device that measures specific biomarkers in sweat. This device performs with accuracy comparable to traditional testing methods, providing a significant advance in the clinical management of cystic fibrosis. The CF patch, a sticker-like monitor worn on the wrist, evaluates sweat volume and chloride levels, crucial for optimizing CFTR modulator therapies. With over 40,000 cystic fibrosis patients in the U.S., this innovation holds the potential to improve patient care and decision-making significantly.
The CF patch measures biomarkers in sweat with accuracy comparable to standard tests, potentially aiding clinical decision-making for cystic fibrosis treatment.
The device is a sticker-like patch worn on the wrist that tracks both sweat volume and chloride levels, optimizing CFTR modulator drug use.
Collection
[
|
...
]